Procurement Footprint
Bio Rad — public-sector procurement footprint
From open OCDS records, AqlData resolved 131 name-spelling variants of Bio Rad into one identity (131 legal entities) and mapped its public-sector footprint: 11 countries, ~$0.7B in awarded value (FX-approx, indicative), across 963+ tracked contracts (2006-01-01 – 2026-05-01).
11
countries
$0.7B
awarded value *
963+
tracked contracts
376
public buyers
* ok-quality, FX-converted contracts only (no_value / no_fx / outlier records excluded). Indicative at current spot FX — not historical rates.
Geographic reach
| Country | Contracts | ~Value ($M) |
|---|---|---|
| FR | 271 | 448.4 |
| IT | 61 | 64.6 |
| EU | 39 | 63.0 |
| ES | 270 | 54.6 |
| GB | 13 | 46.5 |
| PT | 262 | 7.2 |
| + 5 more countries | in full report | — |
Top public buyers
| Buyer | Country | Contracts |
|---|---|---|
| Fundación de Hemoterapia y Hemodonación de Castilla y | ES | 74 |
| Gerencia del Centro de Investigación Biomédica en Red | ES | 41 |
| Centro Hospitalar e Universitário de Coimbra, E. P. E. | PT | 22 |
| + 373 more buyers — every agency, contract-level | — | in full report |
Activity over time
201552
201641
201782
2018100
2019107
202055
202158
202248
202352
202436
20251
20261
The full due-diligence report
All 11 countries, every one of 376 public buyers at the contract level, single-customer revenue concentration, the top-5 buyer split and the buyer-level competitor map — the complete Bio Rad due-diligence brief, delivered within 24 hours.
Order this report — $499Request a worked sample